Latest filing published 25 Jun 2018 for Xeris Pharmaceuticals INC.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Palmetto Partners, Ltd.: trading record in brief
All filings by Palmetto Partners, Ltd. on record concern Xeris Pharmaceuticals Inc. Altogether 4 filings, all relating to 25 June 2018.
Every open-market trade on record is a purchase: 1 purchase worth €1.9M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 25 June 2018 with a transaction in Xeris Pharmaceuticals Inc. The clock since the last published purchase (25 June 2018) now reads 3,059 days. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Palmetto Partners, Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 930,383 sharesCommon StockSEC:0000908662-18-000170:0
- 581,992 sharesCommon StockSEC:0000908662-18-000170:1
- 447,686 sharesCommon StockSEC:0000908662-18-000170:2
- 150,000 shares@ US$15.00100.0% of flowCommon StockSEC:0000908662-18-000170:3Canonical exit: 23 Sept 2018 (T+90)
4 of 4 declarations
